EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Therapeutics in Chronic Urticaria

Melba Muñoz, Emek Kocatürk, Marcus Maurer, Pavel Kolkhir

Immunology and Allergy Clinics of North America · 2024

DOI: 10.1016/j.iac.2024.03.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2024. Verfasst von Melba Muñoz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health; Department of Immunology …. Hauptthemen laut MEDLINE: Chronic Urticaria, Mast Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Florida Agricultural Experiment Station, Genentech, UCB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic urticaria (CU) is a common and long-lasting mast cell-mediated skin disease associated with psychiatric and autoimmune comorbidities, high economic costs, and considerable impact on quality of life. Available therapies show limited efficacy in many CU patients, which may be related to distinct underlying pathophysiology. Targeted and disease-modifying treatments with higher and broader efficacy are needed and are under development for CU. These novel drugs, small molecules, and monoclonal antibodies target mast cells and their receptors, signaling pathways, or mediators and other immune cells. In this article, the authors focus on the most promising emerging therapeutics in advanced development and discuss their potential place in future management of CU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic UrticariaMast CellsHumansAntibodies, MonoclonalMolecular Targeted TherapyAnimalsDisease ManagementQuality of Life

Stichwörter der Autor:innen

BTK inhibitorsBarzolvolimabChronic inducible urticariaChronic spontaneous urticariaChronic urticariaDupilumabNovel treatment

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Institute of Allergology, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health; Department of Immunology and Allergology, Fraunhofer Institute for Translational Medicine and P…

Förderung

  • Florida Agricultural Experiment Station
  • Genentech
  • UCB

Zitieren

APA

Muñoz, M., Kocatürk, E., Maurer, M., & Kolkhir, P. (2024). Emerging Therapeutics in Chronic Urticaria. Immunology and Allergy Clinics of North America. https://doi.org/10.1016/j.iac.2024.03.008

Vancouver

Muñoz M, Kocatürk E, Maurer M, Kolkhir P. Emerging Therapeutics in Chronic Urticaria. Immunology and Allergy Clinics of North America. 2024. doi:10.1016/j.iac.2024.03.008

BibTeX
@article{Muoz2024,
  author = {Muñoz, Melba and Kocatürk, Emek and Maurer, Marcus and Kolkhir, Pavel},
  title = {Emerging Therapeutics in Chronic Urticaria},
  journal = {Immunology and Allergy Clinics of North America},
  year = {2024},
  doi = {10.1016/j.iac.2024.03.008}
}
Kostenlos starten →